To clarify the associations between hypnotic categories and cardiovascular events in insomnia patients.
Key Findings:
Z-drugs did not increase cardiovascular event risk, but a small increase in heart failure risk was noted.
Benzodiazepines raised safety concerns regarding cardiovascular impacts, particularly in females.
Interpretation:
The study indicates varied effects of hypnotics on cardiovascular outcomes, underscoring caution in benzodiazepine use and the relative safety of Z-drugs.
Limitations:
Inability to compare insomnia severity and sleep patterns pre- and post-hypnotic use.
Exclusion of rarely used hypnotics and lack of data on over-the-counter options and non-pharmacological treatments.
Absence of dosage, frequency, and duration data for hypnotic use, leading to potential confounding.
Conclusion:
This study is significant in evaluating the relationship between hypnotics and cardiovascular diseases, highlighting the need for further interventional studies.
